Literature DB >> 20533046

[Achromatopsia].

C M Poloschek1, S Kohl.   

Abstract

Hereditary cone diseases manifest as progressive or stationary disorders. Among the stationary cone disorders autosomal recessive achromatopsia occurs most frequently and begins within the first months of life with nystagmus and photophobia. Color discrimination is not possible, and visual acuity is severely reduced. In addition to a thorough ophthalmic examination, color vision tests and electrophysiology are prerequisites to establish a diagnosis of achromatopsia. A genetic examination is very helpful to distinguish achromatopsia from other stationary cone disorders like X-linked recessive blue cone monochromatism and from progressive cone and cone-rod dystrophies. It is the correct clinical and genetic diagnosis that eventually will allow an individual prognosis, accurate genetic counseling, and the optimal choice of low vision aids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533046     DOI: 10.1007/s00347-010-2178-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  38 in total

1.  The use of tinted contact lenses in the management of achromatopsia.

Authors:  Muriel M Schornack; William L Brown; Dennis W Siemsen
Journal:  Optometry       Date:  2007-01

2.  CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.

Authors:  Naheed Wali Khan; Bernd Wissinger; Susanne Kohl; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

3.  Is colour vision possible with only rods and blue-sensitive cones?

Authors:  A Reitner; L T Sharpe; E Zrenner
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

4.  A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene.

Authors:  Bo Chang; Tanja Grau; Susann Dangel; Ron Hurd; Bernhard Jurklies; E Cumhur Sener; Sten Andreasson; Helene Dollfus; Britta Baumann; Sylvia Bolz; Nikolai Artemyev; Susanne Kohl; John Heckenlively; Bernd Wissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

5.  Typical total monochromacy. A histological and psychophysical study.

Authors:  H F Falls; J R Wolter; M Alpern
Journal:  Arch Ophthalmol       Date:  1965-11

6.  Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2).

Authors:  I A Aligianis; T Forshew; S Johnson; M Michaelides; C A Johnson; R C Trembath; D M Hunt; A T Moore; E R Maher
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

7.  Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders.

Authors:  Alberta A H J Thiadens; Anneke I den Hollander; Susanne Roosing; Sander B Nabuurs; Renate C Zekveld-Vroon; Rob W J Collin; Elfride De Baere; Robert K Koenekoop; Mary J van Schooneveld; Tim M Strom; Janneke J C van Lith-Verhoeven; Andrew J Lotery; Norka van Moll-Ramirez; Bart P Leroy; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Caroline C W Klaver
Journal:  Am J Hum Genet       Date:  2009-07-16       Impact factor: 11.025

8.  Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals.

Authors:  M Michaelides; S Johnson; M P Simunovic; K Bradshaw; G Holder; J D Mollon; A T Moore; D M Hunt
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

9.  Color plates to help identify patients with blue cone monochromatism.

Authors:  E L Berson; M A Sandberg; B Rosner; P L Sullivan
Journal:  Am J Ophthalmol       Date:  1983-06       Impact factor: 5.258

10.  Optical coherence tomography of the macula in congenital achromatopsia.

Authors:  Balázs Varsányi; Gábor Márk Somfai; Balázs Lesch; Rita Vámos; Agnes Farkas
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

View more
  5 in total

Review 1.  Hereditary retinal eye diseases in childhood and youth affecting the central retina.

Authors:  Martin M Nentwich; Guenther Rudolph
Journal:  Oman J Ophthalmol       Date:  2013-09

2.  AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects.

Authors:  Regine Mühlfriedel; Naoyuki Tanimoto; Christian Schön; Vithiyanjali Sothilingam; Marina Garcia Garrido; Susanne C Beck; Gesine Huber; Martin Biel; Mathias W Seeliger; Stylianos Michalakis
Journal:  Front Neurosci       Date:  2017-05-24       Impact factor: 4.677

Review 3.  Retinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy.

Authors:  Stylianos Michalakis; Elvir Becirovic; Martin Biel
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

Review 4.  Achromatopsia: Genetics and Gene Therapy.

Authors:  Stylianos Michalakis; Maximilian Gerhardt; Günther Rudolph; Siegfried Priglinger; Claudia Priglinger
Journal:  Mol Diagn Ther       Date:  2021-12-03       Impact factor: 4.074

5.  Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy.

Authors:  Nan-Kai Wang; Pei-Kang Liu; Yang Kong; Sarah R Levi; Wan-Chun Huang; Chun-Wei Hsu; Hung-Hsi Wang; Nelson Chen; Yun-Ju Tseng; Peter M J Quinn; Ming-Hong Tai; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Int J Mol Sci       Date:  2021-07-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.